1. Neurology. 2005 Dec 27;65(12):1954-7. doi: 10.1212/01.wnl.0000188760.53922.05.
 Epub 2005 Nov 16.

Rapid disease progression correlates with instability of mutant SOD1 in familial 
ALS.

Sato T(1), Nakanishi T, Yamamoto Y, Andersen PM, Ogawa Y, Fukada K, Zhou Z, 
Aoike F, Sugai F, Nagano S, Hirata S, Ogawa M, Nakano R, Ohi T, Kato T, Nakagawa 
M, Hamasaki T, Shimizu A, Sakoda S.

Author information:
(1)Department of Neurology, Osaka University Graduate School of Medicine, Suita, 
Osaka 565-0871, Japan.

Comment in
    Neurology. 2005 Dec 27;65(12):1859-60. doi: 
10.1212/01.wnl.0000192717.25980.b5.

Studies on the clinical course of familial ALS suggest that the duration of 
illness is relatively consistent for each mutation but variable among the 
different mutations. The authors analyzed the relative amount of mutant compared 
with normal SOD1 protein in the erythrocytes from 29 patients with ALS with 22 
different mutations. Turnover of mutant SOD1 correlated with a shorter disease 
survival time.

DOI: 10.1212/01.wnl.0000188760.53922.05
PMID: 16291929 [Indexed for MEDLINE]